Apixaban 5MG

DRUG6 trials

Sponsors

Frank C Sciurba, HK inno.N Corporation, Humanis Saglık Anonim Sirketi, International Bio service, Kafrelsheikh University

Conditions

Antithrombic DrugCOVID-19Cerebral Venous Sinus ThrombosisCerebral Venous ThrombosisHealthyHealthy Volunteer

Phase 1

PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers

CompletedNCT05723510

HK inno.N CorporationHealthy

Start: 2023-03-06End: 2023-07-24Updated: 2023-12-11

Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Healthy, Adult, Human Subjects

CompletedNCT06043297

Humanis Saglık Anonim SirketiAntithrombic Drug

Start: 2023-02-23End: 2023-04-27Updated: 2025-09-15

Bioequivalence Study of Apixaban 5 mg Film-coated Tablets in Healthy Thai Volunteers

Not yet recruitingNCT06388239

International Bio serviceHealthy Volunteer

Start: 2024-08-26End: 2024-09-23Target: 28Updated: 2024-05-24

Phase 3

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

TerminatedNCT04498273

Frank C SciurbaCOVID-19

Start: 2020-09-07End: 2021-08-05Updated: 2022-02-17

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis

RecruitingNCT06531122

Kafrelsheikh UniversityCerebral Venous Thrombosis

Start: 2021-08-01End: 2024-09-20Target: 200Updated: 2024-08-19

Dabigatran Versus Apixaban in Cerebral Venous Thrombosis

RecruitingNCT06551415

Kafrelsheikh UniversityCerebral Venous Sinus Thrombosis

Start: 2021-08-01End: 2024-10-01Target: 200Updated: 2024-08-13

Related Papers

Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial

BMC Infectious Diseases2023-05-151 citations

Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 Registry

International Journal of Clinical Practice2022-01-015 citations

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19

JAMA2021-10-17261 citations